{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:58:13Z","timestamp":1760299093059},"reference-count":29,"publisher":"Japanese Circulation Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1253\/circj.cj-14-0789","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T19:14:23Z","timestamp":1424718863000},"page":"1115-1124","source":"Crossref","is-referenced-by-count":21,"title":["Differential Effects of Strong and Regular Statins on the Clinical Outcome of Patients With Chronic Kidney Disease Following Coronary Stent Implantation\u3000\u2013 The Kumamoto Intervention Conference Study (KICS) Registry \u2013"],"prefix":"10.1253","volume":"79","author":[{"given":"Masanobu","family":"Ishii","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Hokimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Akasaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuteru","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"National Hospital Organization Kumamoto Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Miyao","sequence":"additional","affiliation":[{"name":"National Hospital Organization Kumamoto Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Oshima","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Kumamoto Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Nakao","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Kumamoto Saiseikai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Fukuoka Tokushukai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusuke","family":"Tsunoda","sequence":"additional","affiliation":[{"name":"Kumamoto Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoki","family":"Hirose","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Minamata City Hospital and Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Kajiwara","sequence":"additional","affiliation":[{"name":"Division of Arao City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Division of Kumamoto Rosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Shinbeppu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyasu","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Miyazaki Prefectural Nobeoka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Koide","sequence":"additional","affiliation":[{"name":"Division of Health Insurance Yatsushiro General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Oka","sequence":"additional","affiliation":[{"name":"Division of Health Insurance Hitoyoshi General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Morikami","sequence":"additional","affiliation":[{"name":"Division of Kumamoto City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naritsugu","family":"Sakaino","sequence":"additional","affiliation":[{"name":"Division of Amakusa Regional Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Kumamoto Intervention Conference Study (KICS) Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. <i>Lancet<\/i> 2005; 366: 1267\u20131278.","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sipahi I, Nicholls SJ, Tuzcu EM, Nissen SE. Coronary atherosclerosis can regress with very intensive statin therapy. <i>Cleve Clin J Med<\/i> 2006; 73: 937\u2013944.","DOI":"10.3949\/ccjm.73.10.937"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. <i>N Engl J Med<\/i> 2004; 350: 1495\u20131504.","DOI":"10.1056\/NEJMoa040583"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. <i>JAMA<\/i> 2004; 291: 1071\u20131080.","DOI":"10.1001\/jama.291.9.1071"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Murphy SA, Cannon CP, Wiviott SD, de Lemos JA, Blazing MA, McCabe CH, et al. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). <i>Am J Cardiol<\/i> 2007; 100: 1047\u20131051.","DOI":"10.1016\/j.amjcard.2007.04.053"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. <i>N Engl J Med<\/i> 2005; 352: 1425\u20131435.","DOI":"10.1056\/NEJMoa050461"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB, et al. 2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2014; 63: 2889\u20132934.","DOI":"10.1016\/j.jacc.2013.11.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, et al. Comprehensive risk management for the prevention of cardiovascular disease: Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan \u2013 2012. <i>J Atheroscler Thromb<\/i> 2013; 20: 603\u2013615.","DOI":"10.5551\/jat.15867"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chitose T, Hokimoto S, Oshima S, Nakao K, Fujimoto K, Miyao Y, et al. Clinical outcomes following coronary stenting in Japanese patients treated with and without proton pump inhibitor. <i>Circ J<\/i> 2012; 76: 71\u201378.","DOI":"10.1253\/circj.CJ-11-0699"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. <i>Circulation<\/i> 2007; 116: 2634\u20132653.","DOI":"10.1161\/CIRCULATIONAHA.107.187397"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. <i>Lancet<\/i> 2003; 361: 1149\u20131158.","DOI":"10.1016\/S0140-6736(03)12948-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): A prospective randomised controlled trial. <i>Lancet<\/i> 2006; 368: 1155\u20131163.","DOI":"10.1016\/S0140-6736(06)69472-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. <i>Ann Intern Med<\/i> 2003; 139: 137\u2013147.","DOI":"10.7326\/0003-4819-139-2-200307150-00013"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. <i>Circulation<\/i> 2003; 108: 2154\u20132169.","DOI":"10.1161\/01.CIR.0000095676.90936.80"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM. Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. <i>Kidney Int<\/i> 2003; 63: 696\u2013701.","DOI":"10.1046\/j.1523-1755.2003.00784.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Dan K, Miyoshi T, Ueeda M, Ohtsuka H, Ugawa S, Ohnishi N, et al. Impact of chronic kidney disease on left main coronary artery disease and prognosis in Japanese patients. <i>Circ J<\/i> 2012; 76: 2266\u20132272.","DOI":"10.1253\/circj.CJ-11-1455"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, et al. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: The TNT (Treating to New Targets) study. <i>J Am Coll Cardiol<\/i> 2008; 51: 1448\u20131454.","DOI":"10.1016\/j.jacc.2007.11.072"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ridker PM, MacFadyen J, Cressman M, Glynn RJ. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: A secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. <i>J Am Coll Cardiol<\/i> 2010; 55: 1266\u20131273.","DOI":"10.1016\/j.jacc.2010.01.020"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. <i>Lancet<\/i> 2011; 377: 2181\u20132192.","DOI":"10.1016\/S0140-6736(11)60739-3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. <i>N Engl J Med<\/i> 2005; 353: 238\u2013248.","DOI":"10.1056\/NEJMoa043545"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. <i>N Engl J Med<\/i> 2009; 360: 1395\u20131407.","DOI":"10.1056\/NEJMoa0810177"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hou W, Lv J, Perkovic V, Yang L, Zhao N, Jardine MJ, et al. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: A systematic review and meta-analysis. <i>Eur Heart J<\/i> 2013; 34: 1807\u20131817.","DOI":"10.1093\/eurheartj\/eht065"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Natsuaki M, Furukawa Y, Morimoto T, Sakata R, Kimura T, Investigators CR-KPCRC. Renal function and effect of statin therapy on cardiovascular outcomes in patients undergoing coronary revascularization (from the CREDO-Kyoto PCI\/CABG Registry Cohort-2). <i>Am J Cardiol<\/i> 2012; 110: 1568\u20131577.","DOI":"10.1016\/j.amjcard.2012.07.021"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Dasari TW, Cohen DJ, Kleiman NS, Keyes MJ, Yen CH, Hanna EB, et al. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry). <i>Am J Cardiol<\/i> 2014; 113: 621\u2013625.","DOI":"10.1016\/j.amjcard.2013.11.006"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, et al. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. <i>Circ J<\/i> 2012; 76: 1369\u20131379.","DOI":"10.1253\/circj.CJ-11-1356"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kato K, Yonetsu T, Jia H, Abtahian F, Vergallo R, Hu S, et al. Nonculprit coronary plaque characteristics of chronic kidney disease. <i>Circ Cardiovasc Imaging<\/i> 2013; 6: 448\u2013456.","DOI":"10.1161\/CIRCIMAGING.112.000165"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kono K, Fujii H, Nakai K, Goto S, Shite J, Hirata K, et al. Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease. <i>Kidney Int<\/i> 2012; 82: 344\u2013351.","DOI":"10.1038\/ki.2012.118"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Annema W, von Eckardstein A. High-density lipoproteins. <i>Circ J<\/i> 2013; 77: 2432\u20132448.","DOI":"10.1253\/circj.CJ-13-1025"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Nguyen SV, Nakamura T, Kugiyama K. High remnant lipoprotein predicts recurrent cardiovascular events on statin treatment after acute coronary syndrome. <i>Circ J<\/i> 2014; 78: 2492\u20132500.","DOI":"10.1253\/circj.CJ-14-0380"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/5\/79_CJ-14-0789\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T02:06:24Z","timestamp":1498183584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/5\/79_CJ-14-0789\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-14-0789","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"type":"print","value":"1346-9843"},{"type":"electronic","value":"1347-4820"}],"subject":[],"published":{"date-parts":[[2015]]}}}